[Ip-health] TAC debunks pharma’s myths around patent law reform

Lotti Rutter lotti.rutter at mail.tac.org.za
Thu Oct 10 12:24:33 PDT 2013

(Apologies for cross posting)


*TAC debunks pharma’s myths around patent law reform*

As the Fix the Patent Laws campaign gains traction and South Africa moves
closer towards the kind of intellectual property reform that will vastly
improve access to affordable medicines, a number of claims are being
publicised by the pharmaceutical industry and their allies seeking to
protect their business interests. The purpose of this myth-buster is to
clarify that adopting legal TRIPS safeguards will not only support public
health efforts but also benefit local industry and economic development.

The evidence highlights how South Africa’s current intellectual property
system allows exploitation by foreign companies while impeding the growth
of our local industry. In addition, the paper highlights the flaws in
pharma’s claim that protecting health in South Africa will inhibit the
development of future medicines. Big pharma has systematically evaded
investing in needs driven innovation for neglected diseases and developing
country disease burdens, while simultaneously forcing developing countries
to uphold patents blocking access to life-saving medicines.

*You can find the Treatment Action Campaign (TAC) myth-buster here:


Lotti Rutter

Treatment Action Campaign

More information about the Ip-health mailing list